Literature DB >> 31612308

Muscle aches and pains: do I have leukemia?

Max Deschner1, Chai Phua2,3, Lalit Saini2,3, Anargyros Xenocostas2,3, Uday Deotare2,3.   

Abstract

We describe a 65-year-old man who presented with 'aches and pains' localized to the lower extremities, and was diagnosed with acute myeloid leukemia (AML). We hypothesize that this case represents an atypical presentation of AML with an immune-mediated necrotizing-like myopathy as a possible paraneoplastic manifestation of the disease, which improved after initiating chemotherapy. Our patient received a full course of 7 + 3 chemotherapy with cytarabine and daunorubicin. Proximal leg weakness and pain improved markedly following this treatment, establishing a temporal relationship between the possible paraneoplastic manifestation and treatment of underlying disease. Associations between malignancy and myopathies such as polymyositis and dermatomyositis have been well established in the literature. However, paraneoplastic IMNM is still a rare clinical phenomenon and has infrequently been associated with AML. This case may suggest myopathy and associated muscle 'aches and pains' as possible presenting symptoms of underlying AML, highlighting the heterogeneity of the clinical manifestations of this disease.

Entities:  

Keywords:  Acute myeloid leukemia; Idiopathic inflammatory myopathy; Immune-mediated necrotizing myopathy

Mesh:

Substances:

Year:  2019        PMID: 31612308     DOI: 10.1007/s12185-019-02746-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  8 in total

Review 1.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

2.  High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

Authors:  Yves Allenbach; Jeremy Keraen; Anne-Marie Bouvier; Valérie Jooste; Nicolas Champtiaux; Baptiste Hervier; Yoland Schoindre; Aude Rigolet; Laurent Gilardin; Lucile Musset; Jean-Luc Charuel; Olivier Boyer; Fabienne Jouen; Laurent Drouot; Jeremie Martinet; Tanya Stojkovic; Bruno Eymard; Pascal Laforêt; Antony Behin; Emmanuelle Salort-Campana; Olivier Fain; Alain Meyer; Nicolas Schleinitz; Kuberaka Mariampillai; Aurelie Grados; Olivier Benveniste
Journal:  Brain       Date:  2016-04-17       Impact factor: 13.501

Review 3.  Necrotizing myopathies: an update.

Authors:  Colin Quinn; Johnny S Salameh; Thomas Smith; Nizar Souayah
Journal:  J Clin Neuromuscul Dis       Date:  2015-03

Review 4.  Polymyositis/dermatomyositis associated with acute myelocytic leukemia.

Authors:  Jia-Kun Shen; Yong-Min Ding; Wen-Jing Zhou; Jie Jin
Journal:  Rheumatol Int       Date:  2008-06-19       Impact factor: 2.631

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 6.  Dermatomyositis associated with acute myelocytic leukemia.

Authors:  Ankit Shrivastav; Varun Kumar; Jyotirmoy Pal
Journal:  Rheumatol Int       Date:  2009-05-27       Impact factor: 2.631

Review 7.  Inflammatory myopathies.

Authors:  Anthony A Amato; Steven A Greenberg
Journal:  Continuum (Minneap Minn)       Date:  2013-12

8.  Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: A case report.

Authors:  Lina Su; Yue Yang; Yuan Jia; Xu Liu; Wei Zhang; Yun Yuan; Zhanguo Li
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.